Treating panic disorder with hydroxyzine
Treatments studied
Part of Mental health clinical trials.
This trial tests whether hydroxyzine, a medicine that helps with anxiety, can reduce panic attacks. It may be an option if you have not taken other panic disorder medications recently and are willing to stop current anxiety medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a diagnosis of panic disorder.
- You have not taken any medication for panic disorder in the past 4 weeks.
- You are willing to stop taking benzodiazepines or antidepressants (SSRIs) for the study duration.
- You are not pregnant or breastfeeding, and do not have other mental health conditions or substance abuse issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what factors help people with anxiety disorders respond to treatment and recover. It uses virtual reality and other assessments to understand your anxiety better, which may help guide better treatments in the future. As a participant, you will receive thorough evaluations and may be part of either the anxiety group or a healthy comparison group.
This study tests a new type of therapy that focuses on facing fears to help reduce anxiety. It may be a good fit if you have an anxiety disorder and are looking for treatment.
This study tests whether gentle movement exercises like qigong, combined with other physical activities, can help people with panic disorder feel better. It compares these exercises to standard care.
This study tests a new medicine (SEP-363856) for adults with generalized anxiety disorder to see if it reduces anxiety symptoms and is safe. It may help if other treatments haven't worked well.
This trial tests an investigational medication to see if it can reduce anxiety symptoms in adults with generalized anxiety disorder. Participants will receive the study drug and be monitored for safety and effectiveness.
This study tests whether the antidepressant escitalopram can reduce asthma attacks in people who have frequent, severe flare-ups despite using their regular inhalers. It may help if you have moderate to severe asthma and have had 3 or more attacks needing steroids in the past year.
Hear when a new Panic Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.